New shot at hope: groundbreaking injection tested for tough cancers
NCT ID NCT07243626
Summary
This study is testing whether adding a new immunotherapy drug called envafolimab to standard chemotherapy works better for advanced soft tissue sarcoma. The trial will enroll 15 adults who have not had prior treatment for their cancer. Researchers hope this combination will better control the cancer by helping the immune system attack tumors alongside chemotherapy.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOFT TISSUE SARCOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.